Castor Maritime Inc. Announces Compliance with Nasdaq Minimum Bid Price Requirement
LIMASSOL, Cyprus, April 15, 2024 (GLOBE NEWSWIRE) — Castor Maritime Inc. (NASDAQ: CTRM), (“Castor”, or the “Company”), a diversified global […]
WalkMe Cements Category Leadership with Continued AI Innovation, Industry Recognition, and Financial Growth
SAN FRANCISCO, April 15, 2024 (GLOBE NEWSWIRE) — WalkMe Ltd. (NASDAQ: WKME), a leading provider of digital adoption solutions, today […]
HeartCore Signs 14th Go IPO Contract
NEW YORK and TOKYO, April 15, 2024 (GLOBE NEWSWIRE) — HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), a […]
iPower to Participate in the Water Tower Research Fireside Chat Series on April 18
RANCHO CUCAMONGA, Calif., April 15, 2024 (GLOBE NEWSWIRE) — iPower Inc. (Nasdaq: IPW) (“iPower” or the “Company”), a tech and […]
CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin)
BERKELEY HEIGHTS, N.J., April 15, 2024 (GLOBE NEWSWIRE) — CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and […]
Microbot Medical Shares Status Following Recent Geopolitical Events
All Regulatory, Clinical, Operational and Pre-Commercial Activities Continue to Stay on Track Despite the On-going Situation in Israel Company Believes […]
Marathon Digital Holdings Appoints Manoj Narender Madnani as Managing Director for EMEA Expansion
Fort Lauderdale, FL, April 15, 2024 (GLOBE NEWSWIRE) — Marathon Digital Holdings, Inc. (NASDAQ:MARA) (“Marathon” or “Company”), one of the […]
Mobile-health Network Solutions Makes History as First APAC Telehealth Company Listed on US Stock Exchange
SINGAPORE, April 15, 2024 (GLOBE NEWSWIRE) — Mobile-health Network Solutions (Nasdaq: MNDR), a pioneering Asia-Pacific (APAC) telehealth provider, celebrates its […]
Reviva Announces FDA Alignment on Brilaroxazine Clinical Trials for NDA in Schizophrenia
– FDA acceptance of 4-week global registrational Phase 3 RECOVER-2 study – – Two positive 4-week studies plus a 12-month […]
Atossa Therapeutics and Quantum Leap Healthcare Announce I-SPY 2 Clinical Trial to Evaluate (Z)-Endoxifen in Combination with Abemaciclib (VERZENIO®) in Women with ER+/HER2- Breast Cancer
SEATTLE, April 15, 2024 (GLOBE NEWSWIRE) — Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”) and Quantum Leap Healthcare […]
